Acquired microvascular dysfunction in inflammatory bowel disease: Loss of nitric oxide-mediated vasodilation.
about
Acetylcholinesterase activity, cohabitation with floricultural workers, and blood pressure in Ecuadorian childrenLife and death at the mucosal-luminal interface: New perspectives on human intestinal ischemia-reperfusionSmoking in inflammatory bowel diseases: good, bad or ugly?Endothelial caveolin-1 regulates pathologic angiogenesis in a mouse model of colitis.Circulating microparticles from Crohn's disease patients cause endothelial and vascular dysfunctions.Hypoxia inducible factor (HIF)-1 coordinates induction of Toll-like receptors TLR2 and TLR6 during hypoxiaWhere are all the Mycobacterium avium subspecies paratuberculosis in patients with Crohn's disease?Influence of smoking on colonic gene expression profile in Crohn's disease.Venous thrombosis and prothrombotic factors in inflammatory bowel disease.Speckle Tracking Stress Echocardiography Uncovers Early Subclinical Cardiac Involvement in Pediatric Patients with Inflammatory Bowel Diseases.Targeting the A2B adenosine receptor during gastrointestinal ischemia and inflammationEtiopathogenesis of inflammatory bowel diseasesReview article: smoking cessation as primary therapy to modify the course of Crohn's disease.Effect of IBD sera on expression of inducible and endothelial nitric oxide synthase in human umbilical vein endothelial cells.Endothelial dysfunction in chronic inflammatory diseasesBowel perfusion measured with dynamic contrast-enhanced ultrasound predicts treatment outcome in patients with Crohn's diseaseRelationship between inflammation and tissue hypoxia in a mouse model of chronic colitis.Mechanisms of disease: nicotine--a review of its actions in the context of gastrointestinal disease.The Role of the Mesentery in Crohn's Disease: The Contributions of Nerves, Vessels, Lymphatics, and Fat to the Pathogenesis and Disease Course.Radiation induced small bowel "web" formation is associated with acquired microvascular dysfunction.Role of the endothelium in inflammatory bowel diseases.Haemostatic system in inflammatory bowel diseases: new players in gut inflammation.Venous and arterial disease in inflammatory bowel disease.Activated eosinophils in association with enteric nerves in inflammatory bowel disease.Hypoxia and metabolic factors that influence inflammatory bowel disease pathogenesis.Ulcerative colitis in smokers, non-smokers and ex-smokersRelationship among circulating leukocytes, platelets, and microvascular responses during induction of chronic colitisThrombosis in inflammatory bowel diseases: what's the link?Drug management of visceral pain: concepts from basic research.Focus on oxidative stress in the cardiovascular and renal systems.The vasculature and inflammatory bowel disease: contribution to pathogenesis and clinical pathology.Paradox of simultaneous intestinal ischaemia and hyperaemia in inflammatory bowel disease.The roles of purinergic signaling during gastrointestinal inflammation.The Human Microcirculation: Regulation of Flow and BeyondRisk of Inflammatory Bowel Disease with Oral Contraceptives and Menopausal Hormone Therapy: Current Evidence and Future Directions.The implications of oxidative stress and antioxidant therapies in Inflammatory Bowel Disease: Clinical aspects and animal models.The intestinal microvasculature as a therapeutic target in inflammatory bowel disease.Crohn's disease activity assessed by Doppler sonography: the role of aortic flow parameters.Bacteria- and host-derived mechanisms to control intestinal epithelial cell homeostasis: implications for chronic inflammation.Multiple pathogenic roles of microvasculature in inflammatory bowel disease: a Jack of all trades.
P2860
Q23915387-20E9528C-E16F-4E8C-ABCC-42957739FD2BQ26766046-6D2B43D1-2F5A-45DB-AEBB-2F49E0F581FCQ28260531-1AF912CA-0983-48C0-BED1-7DDD3692936FQ30540161-BD695400-3285-45E2-9820-6864ADCBA11DQ31137300-2E42C164-75B9-43ED-8E4F-14BADCB369D5Q33312383-4A52B877-CB59-4F82-9F33-6EF7C270A6F9Q33422976-D2D1BEFB-9402-4D04-A2D3-7783BD14BD63Q33482165-C6C949B9-50ED-4CE8-B125-47412367E1EFQ33564092-B2F44FDF-016F-41A7-B934-51E90EEB880AQ33774260-7D4AEE9C-F7FB-4F31-8EA4-596201258077Q33830064-FD78882D-BA10-4831-987F-2BEF6451BB03Q33866988-4D45ECD2-6F31-44AE-A400-761ACB34FFCAQ33986263-EC20ABA8-4AE5-4FD0-8008-AE040E617481Q34012826-107294BA-C33F-4C11-AE9C-A16ABB819053Q34072179-399456AA-C60B-433C-8A77-BCC41B15F0E7Q34421399-371CEAB9-F348-40A9-8060-1F756BB65319Q34453775-57FB3FFF-5784-40BE-9766-8197D253E514Q34476515-78CF6471-00DA-4C31-9E7B-B8E3AA18D4A8Q34526079-C7B406AA-7CFF-44AB-BE63-E4155AA48B42Q34560451-00115ECB-22D5-47AD-AB95-7DF9351329CEQ34579746-10C7775D-A375-442E-B0DB-E48E5A1910CDQ34579752-FC310058-2046-4E45-A6EC-25AB2703A7A3Q34714365-E45480AB-18AA-4334-9DF0-9384A531CED0Q34745442-3F235CDA-7159-4B57-A618-8B2312022E7CQ34977591-F63060F2-69BE-4CE5-9F9A-ED8FA6087D65Q35065326-92EE9899-3C33-45F8-8D54-C3795E4B8E20Q35154179-6AA11A1E-30E6-4A70-B33E-9C8E059A217FQ35368162-B82E09E9-B9A7-4010-AF63-D20979A0C5AFQ35947915-C37996D8-569C-4FBF-BDD8-1967866EF337Q35983896-6C1ABCD3-2265-43C3-B7FA-9DC49E648D9CQ36056593-FD08131B-A2C8-4010-AD62-A48C52840237Q36264902-9602C91E-5A71-48CD-8C05-5B30BB6AECBBQ36448977-B735106B-2DE9-4D9D-8532-42403512B385Q36547176-5DA5CE3E-2266-4F07-8E64-EEB49BDBED1AQ36576490-DDD7507D-D83F-4BC7-BEDE-E732EE2D7D4CQ36606775-9B741977-A6D1-42B4-B042-BCE08E0E52A6Q36631424-43E93FFC-0344-4C1D-8606-3B121FD94E57Q36791650-700C0A4E-BFCA-4BD1-8F74-085A2C15E4FAQ36809889-A76130EA-512D-41CB-9253-FE55A6542D95Q37155166-1889B9D7-1B68-49CA-BFE9-7E2A5A854C65
P2860
Acquired microvascular dysfunction in inflammatory bowel disease: Loss of nitric oxide-mediated vasodilation.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Acquired microvascular dysfunc ...... c oxide-mediated vasodilation.
@en
Acquired microvascular dysfunc ...... c oxide-mediated vasodilation.
@nl
type
label
Acquired microvascular dysfunc ...... c oxide-mediated vasodilation.
@en
Acquired microvascular dysfunc ...... c oxide-mediated vasodilation.
@nl
prefLabel
Acquired microvascular dysfunc ...... c oxide-mediated vasodilation.
@en
Acquired microvascular dysfunc ...... c oxide-mediated vasodilation.
@nl
P2093
P1433
P1476
Acquired microvascular dysfunc ...... c oxide-mediated vasodilation.
@en
P2093
David D Gutterman
David G Binion
Mary F Otterson
Ossama A Hatoum
P356
10.1016/S0016-5085(03)00699-1
P407
P577
2003-07-01T00:00:00Z